Riverhead Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $162K | Buy |
5,886
+200
| +4% | +$5.51K | 0.01% | 1205 |
|
|
2019
Q2 | $188K | Hold |
5,686
| – | – | 0.01% | 1175 |
|
|
2019
Q1 | $199K | Hold |
5,686
| – | – | 0.01% | 1125 |
|
|
2018
Q4 | $189K | Hold |
5,686
| – | – | 0.01% | 1097 |
|
|
2018
Q3 | $286K | Buy |
5,686
+1,000
| +21% | +$50.3K | 0.01% | 1029 |
|
|
2018
Q2 | $281K | Hold |
4,686
| – | – | 0.01% | 925 |
|
|
2018
Q1 | $215K | Buy |
4,686
+200
| +4% | +$9.18K | 0.01% | 1034 |
|
|
2017
Q4 | $179K | Buy |
4,486
+900
| +25% | +$35.9K | 0.01% | 1130 |
|
|
2017
Q3 | $143K | Buy |
3,586
+524
| +17% | +$20.9K | 0.01% | 1141 |
|
|
2017
Q2 | $132K | Buy |
3,062
+1,462
| +91% | +$63K | 0.01% | 1106 |
|
|
2017
Q1 | $50K | Buy |
1,600
+200
| +14% | +$6.25K | ﹤0.01% | 1263 |
|
|
2016
Q4 | $35K | Hold |
1,400
| – | – | ﹤0.01% | 1325 |
|
|
2016
Q3 | $35K | Sell |
1,400
-778
| -36% | -$19.5K | ﹤0.01% | 1282 |
|
|
2016
Q2 | $58K | Sell |
2,178
-6,966
| -76% | -$186K | ﹤0.01% | 1294 |
|
|
2016
Q1 | $140K | Sell |
9,144
-356
| -4% | -$5.45K | ﹤0.01% | 1312 |
|
|
2015
Q4 | $128K | Buy |
+9,500
| New | +$128K | ﹤0.01% | 1306 |
|